Cas no for 49839-99-8,4-(2-Nitrovinyl)indole ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich - PharmaSources.com

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 49839-99-8

49839-99-8

[CAS Name] 4-(2-Nitrovinyl)indole

[Formula] C10H8N2O2

Search Products Post Sourcing Request

Basica Info

[CAS Name]4-(2-Nitrovinyl)indole
[Alias]4-(2-Nitrovinyl)-1H-indole; Indole-4-nitrylethylene; 4-[(E)-2-nitroethenyl]-1H-indole
[Number]49839-99-8
[EINECS]
[Formula]C10H8N2O2
[Molecular weight]188.1827

[Melting point]161-163℃
[Boiling point]406.1°C at 760 mmHg
[Density]1.95E-06mmHg at 25°C
[Flash point]199.4°C

49839-99-8 Suppliers

Company

Main Products

Jiangsu Magic Biotechnology Co., Ltd

4-(2-硝基乙烯基)吲哚化学性质熔点:161-163°C沸点:406.1±20.0°C(Predicted)密度:1.352酸度系Chemicalbook数(pKa):16.13±0.30(Predicted)CAS数据库:49839-99-8(CASDataBaseReference)

Send Inquiry

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2025 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182 沪公网安备31010402010101号
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight January 2025

PharmaSources Customer Service